A major breakthrough in diabetes treatment is arising with the advent of rapidly breaking down GLP-1 medications. These cutting-edge formulations bypass the traditional injection process , offering a easy oral option for individuals living with this disease . The ability to rapidly dissolve in th

Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are expecting strong results driven by the robust sales of Lilly's blockbuster medications, particularly its insulin portfolio. However, th